proline has been researched along with Cytomegalovirus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hidaka, Y; Nakajima, H; Niwa, S; Ogawa, K; Shimbara, N; Tanahashi, N; Tanaka, K; Yamasaki, N | 1 |
| Borthwick, AD; Exall, AM; Haley, TM; Jackson, DL; Mason, AM; Weingarten, GG | 1 |
2 other study(ies) available for proline and Cytomegalovirus
| Article | Year |
|---|---|
Contribution of proline residue for efficient production of MHC class I ligands by proteasomes.
Topics: Amino Acid Sequence; Animals; Antigen Presentation; Cysteine Endopeptidases; Cytomegalovirus; Histocompatibility Antigens Class I; Immediate-Early Proteins; Immunodominant Epitopes; Ligands; Liver; Mice; Molecular Sequence Data; Multienzyme Complexes; Oligopeptides; Proline; Proteasome Endopeptidase Complex; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Substrate Specificity; T-Lymphocytes, Cytotoxic | 1998 |
Pyrrolidine-5,5-trans-lactams as novel mechanism-based inhibitors of human cytomegalovirus protease. Part 3: potency and plasma stability.
Topics: Antiviral Agents; Cytomegalovirus; Dansyl Compounds; Drug Stability; Half-Life; Humans; Inhibitory Concentration 50; Lactams; Proline; Protease Inhibitors; Pyrrolidines; Spectrometry, Mass, Electrospray Ionization | 2002 |